Synergy Innovation시너지이노베이션
048870 · KOSDAQ · ₩048870 · 시너지이노베이션
- Market cap
- ₩123B
- Enterprise value
- ₩90B
- P/E
- 12.3×
- P/B
- 0.6×
- Dividend yield
- 0.0%
- ROE
- 4.6%
- Net margin
- 8.6%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−46.3% from the high
₩1,329Today: ₩1,336 – ₩1,401₩2,600
Returns
- 1W−1.2%
- 1M−13.1%
- 3M−3.3%
- 6M−33.5%
- YTD−40.4%
- 1Y−45.4%
- Volume today
- 235,328
- 1.0× the 20-day average
- Traded today
- ₩320M
- Listed shares
- 88,106,963
- EPS (12 months)
- ₩114
- Earnings yield 8.1%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 43 of 100 (50 is a normal day for this stock).
- MomentumWeak-11.5% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Synergy Innovation stock overview
Synergy Innovation (시너지이노베이션, KRX: 048870) is listed on KOSDAQ, in the Medical & precision devices sector. The company manufactures and sells microbial culture media, mainly used for environmental monitoring in pharmaceutical manufacturing, and supplies them to hospitals, testing centers and pharmaceutical companies across Korea. Its shares closed at ₩1,397 on Oct 29, 2026, up 0.43% on the day, giving it a market value of ₩123B.
Key facts
- Market cap
- ₩123B
- Sector
- Medical & precision devices
- Latest price change
- +0.43%
- As of
- Oct 29, 2026
- Main business
- The company manufactures and sells microbial culture media, mainly used for environmental monitoring in pharmaceutical manufacturing, and supplies them to hospitals, testing centers and pharmaceutical companies across Korea.
Quick answers about Synergy Innovation
- What does Synergy Innovation do?
- The company manufactures and sells microbial culture media, mainly used for environmental monitoring in pharmaceutical manufacturing, and supplies them to hospitals, testing centers and pharmaceutical companies across Korea. Its business is organized into bio-technology, medical, and health functional food segments, with a subsidiary also conducting drug research and development. Products are made in clean rooms and automated production lines holding ISO 13485 and medical device KGMP certifications.
- What is the market cap of Synergy Innovation?
- The market capitalisation of Synergy Innovation was ₩123B at the close on Oct 29, 2026.
- Who are the largest shareholders of Synergy Innovation?
- According to the latest official filings, the largest reported holders are Synergy Partners (38.27%, as of May 21, 2026); EMERGING MARKETS CORE EQUITY 2 PORTFOLIO (0.23%, as of Jul 31, 2026); Dimensional Emerging Markets Core Equity 2 ETF (0.06%, as of Jul 31, 2026).
- When is the next earnings report from Synergy Innovation?
- Korean companies rarely announce results dates in advance. Based on when Synergy Innovation filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
Company profile
The company manufactures and sells microbial culture media, mainly used for environmental monitoring in pharmaceutical manufacturing, and supplies them to hospitals, testing centers and pharmaceutical companies across Korea. Its business is organized into bio-technology, medical, and health functional food segments, with a subsidiary also conducting drug research and development. Products are made in clean rooms and automated production lines holding ISO 13485 and medical device KGMP certifications.
Written by AI from the company's latest annual report.
- Korean name
- 시너지이노베이션
- CEO
- 박진형
- Founded
- Apr 1998
- Listed
- Aug 2004
- Listed shares
- 88,106,963
- Fiscal year ends
- Month 12
Similar companies
- TSE131290 · ₩2.9T₩260,500−5.27%
- Kctech281820 · ₩1.9T₩97,500+2.09%
- Classys214150 · ₩1.7T₩26,800−0.74%
- Park Systems140860 · ₩1.6T₩228,500−0.44%
- DI003160 · ₩1.2T₩43,500+0.46%
- Curiox Biosystems445680 · ₩1T₩60,600−2.88%
- LivsMed491000 · ₩1T₩40,450−7.33%
- Seers458870 · ₩907B₩23,650−3.86%
Recent filings
See all- [Amended Filing] Major Matters Report (Decision on Transfer of Equity Securities of Another Company)Sep 30, 2026
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before MaturitySep 22, 2026
- [Amended Filing] Major Matters Report (Decision on Transfer of Equity Securities of Another Company)Sep 9, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- [Amended Filing] Major Matters Report (Decision on Transfer of Equity Securities of Another Company)Aug 4, 2026
Titles in Korean until English translations are added.
Also known as: Synergy Innovation / 시너지이노베이션 / 048870 / KRX:048870
Source: KRX statistical information